Should I Buy GNMSF Stock in 2026?
Data-driven analysis and honest assessment for Genmab A/S
Current Price: $330.37P/E: 14.5
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Attractive P/E of 14.5
Slow growth of 1%
Thin margins (0% net)
Financial health data limited
Strong FCF yield of 5.1%
No recent insider activity
Key Investment Metrics
Current Price
$330.37
P/E Ratio
14.47
Revenue Growth
0.2%
Profit Margin
0.4%
Market Cap
$20.4B
Dividend Yield
None
How GNMSF Compares to Competitors
Understanding how GNMSF stacks up against peers helps inform your investment decision.
How GNMSF Compares to Peers
Upcoming Events for GNMSF
+5 Reasons TO Buy GNMSF
1. High gross margins of 94%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
2. Attractively valued at 14.5x earnings
moderateA P/E ratio of 14.5 is below the market average of ~20x, suggesting the stock may be undervalued.
3. High free cash flow yield of 5.1%
moderateFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
-5 Reasons NOT to Buy GNMSF
1. Thin profit margins of 0.4%
high riskLow margins provide little cushion against cost increases or pricing pressure.
2. Minimal revenue growth
low riskGrowth of 0.2% barely keeps pace with inflation.
Who Should Buy GNMSF?
Investment Profile
Risk Level
Medium
Recommended Holding Period
3-5 years
Best For:
- ✓
Value Investors
P/E of 14.5 offers margin of safety
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
Consider These Alternatives
If you're interested in GNMSF, compare these Healthcare peers:
Pro tip: Compare GNMSF directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for GNMSF
Frequently Asked Questions
What is GNMSF stock price today?
GNMSF (Genmab A/S) stock is trading at $330.37 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is GNMSF stock going up or down today?
GNMSF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy GNMSF stock now?
The decision to buy GNMSF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is GNMSF a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for GNMSF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is GNMSF stock overvalued or undervalued?
GNMSF currently trades at a P/E ratio of 14.47, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if GNMSF is fairly priced.
What is GNMSF's P/E ratio?
GNMSF has a price-to-earnings (P/E) ratio of 14.47, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is GNMSF's market cap?
GNMSF (Genmab A/S) has a market capitalization of $20.35 billion, making it a mid-cap stock.
What is GNMSF's price to book ratio?
GNMSF trades at a price-to-book (P/B) ratio of 3.54, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Genmab A/S
Full Stock Analysis
Complete GNMSF overview with charts and data
Is GNMSF Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how GNMSF stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Genmab A/S
Complete GNMSF Analysis
Compare GNMSF With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.